INTRODUCTION
The inherited deficiency of purine nucleoside phosphorylase in humans is associated with a severe deficiency of thymus-derived lymphocytes or T cells but with minimally impaired or normal function of the bone marrow-derived or B lymphocytes. The deficiency of purine nucleoside phosphorylase seems to be causally related to the immunodeficiency since the inherited deficiency of adenosine deaminase, an enzyme which functionally precedes purine nucleoside phosphorylase, is also associated with a T-cell dysfunction and a variably impaired B-cell func- Dr tion. There have been several hypotheses proposed to explain the immune dysfunction in these enzymedeficient disorders. The two prominent hypotheses are a cyclic AMP-mediated lymphotoxicity (1), and a pyrimidine starvation as originally proposed by Green and Chan (2) . In a cell culture model system using pharmacological simulation of adenosine deaminase deficiency we have eliminated the hypothesis that cyclic AMP mediates the toxic effects of adenosine deaminase deficiency. We have also demonstrated the ability of the pyrimidine nucleoside, uridine, to reverse the cytotoxic effects of the simulated adenosine deaminase deficiency, and of simulated purine nucleoside phosphorylase deficiency (3) . In two independent laboratories we have characterized the disordered purine metabolism in two unrelated patients deficient in purine nucleoside phosphorylase (4, 5) . Both patients excrete in their urine large quantities of inosine and guanosine and their respective 2'-deoxyribonucleosides. During Chromatography. High pressure liquid chromatographic assays of orotic acid in the urine were performed on an ALTEX high pressure system with a 152 dual wavelength ultraviolet detector. The samples (25 pl) were applied to a Partisil 10-SAX column (H. Reeve Angel & Co., Inc., Clifton, N. J.) and eluted at a flow rate of 2 ml/min with 7 mM potassium phosphate, pH 2.8. The eluates were monitored at 254 and 280 nm. Standard solutions of orotic acid and uridine monophosphate were employed as markers.
RESULTS
The isotope dilution technique for determining orotic acid in the urine samples provided a technique sufficiently sensitive to detect 5 ,uM orotic acid even in the presence of 10 mM inosine, as depicted in Fig. 1 acid to orotidylate. The limiting factor is usually a relative or absolute deficiency of orotate phosphoribosyltransferase even though in some cases the primary defects are in urea metabolism (11) . The purine nucleoside phosphorylase-deficient patients do not Another mechanism by which the purine nucleoside phosphorylase deficiency might result in orotic aciduria would be the inhibition of orotate phosphoribosyltransferase by an abnormal metabolite accumulated in the absence of the phosphorylase. Inosine at concentrations as high as 10 mM does not inhibit orotate phosphoribosyltransferase in vitro.
Whether purine nucleoside phosphorylase immunodeficiency and adenosine deaminase immunodeficiency results from a similar mechanism remains to be determined. One report states that orotic acid was not found in the urine of an adenosine deaminasedeficient patient, but the methods employed and sensitivities thereof were not described (15 
